TWI241296B - Process for preparing triazolopyrimidine derivatives - Google Patents
Process for preparing triazolopyrimidine derivatives Download PDFInfo
- Publication number
- TWI241296B TWI241296B TW91108486A TW91108486A TWI241296B TW I241296 B TWI241296 B TW I241296B TW 91108486 A TW91108486 A TW 91108486A TW 91108486 A TW91108486 A TW 91108486A TW I241296 B TWI241296 B TW I241296B
- Authority
- TW
- Taiwan
- Prior art keywords
- chemical formula
- procedure
- patent application
- scope
- acid
- Prior art date
Links
Landscapes
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Description
1241296 九、發明說明: 【發明之技術領域】 本發明係關於一種製備具有下列化學式(j )之 三唑嘧啶衍生物之新穎程序:1241296 IX. Description of the invention: [Technical field of the invention] The present invention relates to a novel procedure for preparing a triazolopyrimidine derivative having the following chemical formula (j):
美白ί IRl係代表風原子,具有—至十個碳原子之炫 : 土,具有三至六個碳原子之環烷基自由基或具 個碳原子之稀基自由基;1係代表氫原子, ::原:二,有一至十個碳原子之經基烧基自 ί :;时原子之烧基自由U“系代表氫原 Γ i 四個碳原子之經基烷基自由I或具有- 至四個碳原子之烷基自由基。 有 L先前技術】 具有化學式(〗)之化合物 3,689,488號中揭露。它們對;、,專利 效,因此可以用好二預防支乳管痙攣非常: 關之疾病’例如:氣喘或支氣管炎。於 3观權號中描述之一種製 、吳國專利』 合物之程序係簡述如下: 有化子式(I )之< (a)二胺基-!,2,4-三唑之製備(顯示於#/令、 1241296 ΝΗ ΗΝ,Whitening IR1 represents wind atoms, with dazzling to-ten carbon atoms: earth, cycloalkyl radicals with three to six carbon atoms or dilute radicals with one carbon atom; 1 represents hydrogen atom, :: Original: Two, via radicals with one to ten carbon atoms. From: 时: Atomic radical radical U "represents hydrogen radical Γ i. Four carbon atoms via radical alkyl radical I or have-to An alkyl radical of four carbon atoms. There is a prior art] Compound No. 3,689,488 disclosed in Chemical Formula (〗). They are patented, so they can be used to prevent bronchospasm. Very: related diseases 'For example: asthma or bronchitis. The procedure for making a compound of the Wu State patent described in the Quanguan number is briefly described as follows: <(a) diamine group with chemical formula (I)-! Preparation of 2,4-triazole (shown in # / 令, 1241296 ΝΗ ΗΝ,
R4 SR4 S
r4—n=c=s 4 hours R Λ ^Et H R4 - Pr, or Bn 1 N H 、N 、S> H •HBr several daysr4—n = c = s 4 hours R Λ ^ Et H R4-Pr, or Bn 1 N H, N, S > H • HBr several days
NN
EtI R4 人S』tEtI R4 person S 』t
HH
HH
3-16 h R 1 Et 1 N H 圖1 (b )三唑嘧啶之製備(顯示於嚴2中) HN-N Ά 夂N,R4+ Η Η R^O R23-16 h R 1 Et 1 N H Figure 1 (b) Preparation of triazopyrimidine (shown in Yan 2) HN-N Ά 夂 N, R4 + Η Η R ^ O R2
Rs (II)Rs (II)
Base 2 days 1SU JJ ΛBase 2 days 1SU JJ Λ
r2 'R2 + hnX I N 丄、v - Ri 7 i r4 1 Mixture 10 daysr2 'R2 + hnX I N 丄, v-Ri 7 i r4 1 Mixture 10 days
when R4=Bn Hydrogenolysiswhen R4 = Bn Hydrogenolysis
Separation 圖2 前述程序中之製造有幾項缺點。第一,製備二胺 基-1,2,4-三唑(羼/ )之程序需花費數天時間,非常沒 有效率。第二,由二胺基-1,2,4-三唑及具有化學式 (Π )之α,/3 -未飽和酸衍生物之縮合而產生異構物 1241296 之混合物係無選擇性的, 2)。第三,氫解笨甲基圖匕茜要進一步之純化(屬 有化學式(I )之三唑嘧(”之去保護)以產生具 。。由商業觀點來看:;=費10天’非常耗時(屬 效率且花費昂貴的。”、、員不於圖1及圖2之程序係無 【發明内容】 古—^ 1明之目的係克服前述之缺點,提供一 τ . 一 且更具逛擇性之製備具有化學式 丄)之二唑嘧啶衍生物之程序 本發明提供一種製備具有化學式(1)之三唑痛 咬衍生物,程序。此程序至少包含:由具有化學^ (V 1之二烷基氰基二硫基亞胺基碳酸酯快速製備具 有化子式(111 )之二胺基-1,2,4·三唑;有效地將胺基 保護(protection)及去保護(depr〇tecti〇n);以及選 擇性細合具有化學式(Π )之α,万·未飽和酸衍生物及 具有化學式(VI)之亞胺。 依據本發明之製備具有化學式(I )之三唾。密σ定 衍生物之程序至少包含四個步驟··第一步係有效製備 具有化學式(皿)之二胺基-1,2,4_三唾,其中1至2 當量之具有化學式(IV )之烷基胺係於室溫下慢慢加 入具有化學式(V)之二烷基氰基二硫基亞胺基碳酸 酯(1當量)及適當溶劑之混合物中,接著加熱回流後 一滴滴加入1至4當量之聯胺。 1241296 n2h4Separation Figure 2 There are several disadvantages to the manufacturing in the previous procedure. First, the procedure for preparing diamine-1,2,4-triazole (唑 /) takes several days and is very inefficient. Secondly, the mixture produced by the condensation of diamino-1,2,4-triazole and an α, / 3-unsaturated acid derivative having the formula (Π) to produce an isomer 1241296 is non-selective, 2 ). Thirdly, the hydrogenolysis of methyl sulfonium must be further purified (which is the deprotection of the triazopyrimidine of the chemical formula (I)) to produce a product. From a commercial point of view: == 10 days' very Time-consuming (efficient and expensive.), The program is not as detailed in Figure 1 and Figure 2. [Abstract] The purpose of the ancient ^ 1 is to overcome the aforementioned shortcomings, to provide a τ. The present invention provides a procedure for preparing a triazole pyrimidine derivative having the chemical formula (i). The present invention provides a procedure for preparing a triazole pain bite derivative having the chemical formula (1). This procedure includes at least: Alkyl cyano dithioimino carbonate quickly prepares diamine-1,2,4 · triazoles with the chemical formula (111); effectively protects and deprotects amino groups tecti〇n); and selective blending of α, 10,000 · unsaturated acid derivatives with chemical formula (Π) and imines with chemical formula (VI). Preparation of three salivas with chemical formula (I) according to the present invention. Dense The σ-determining derivative process includes at least four steps. The first step is to effectively prepare The diamine-1,2,4_trisialyl group in the chemical formula (Dish), in which 1 to 2 equivalents of the alkylamine having the chemical formula (IV) is slowly added at room temperature to the dioxane having the chemical formula (V) In a mixture of cyano dithioiminocarbonate (1 equivalent) and a suitable solvent, 1 to 4 equivalents of hydrazine are added dropwise after heating under reflux. 1241296 n2h4
(III) Ν' ,CN Rl-NH2-Solvent (IV)(III) Ν ', CN Rl-NH2-Solvent (IV)
,CN, CN
N 义N meaning
RS^SR (V) 圖3 圖3係顯示製備具有化學式(m)之二胺基el,2,4-三 唑之流程,其中Ri與前述定義相同;r代表具有一至 四個碳原子之烷基自由基;溶劑可使用水,乙腈或 如:曱醇、乙醇、丙醇或丁醇等之醇類溶劑。 第二步係製備具有化學式(VI )之亞胺,其中1 至7當量之具有化學式(VH)之醛類與1當量之具有 化子式(皿)之二胺基-1,2,4-三唾係於5〇〜i5〇°C下, 且有酸催化劑(0至i當量)存在之有機溶劑中反應。RS ^ SR (V) Fig. 3 Fig. 3 shows a process for preparing a diamino group el, 2,4-triazole having the chemical formula (m), wherein Ri has the same definition as above; r represents an alkane having one to four carbon atoms Radicals; solvents can be water, acetonitrile or alcohol solvents such as methanol, ethanol, propanol or butanol. The second step is to prepare an imine having the chemical formula (VI), where 1 to 7 equivalents of the aldehydes having the chemical formula (VH) and 1 equivalent of the diamine group having the chemical formula (dish) -1,2,4- Trisalene is reacted in an organic solvent at 50 ~ i50 ° C and in the presence of an acid catalyst (0 to i equivalent).
、N H, N H
±1丄>—IN U ΛΝΧΝΗ2+ RsAh R H catalyst (III) (VII)± 1 丄 >-IN U ΛΝχΝΗ2 + RsAh R H catalyst (III) (VII)
、N H HN—NΛ又 n=\ (VI) R8 圖4 之垸αΠΙΆ代表具有一至十個碳原子 腈,甲笨,-甲茉,〜取代之本基,〉谷劑可使用乙 乳笨,三氣曱院,二氯甲.Ρ, 自:―氣乙烷或如:Ψ醇、乙醇、丙醇或 : 催化劑可不加’或催化劑可為如:U ϊ 本石頁酸、硫酸或鹽酸之有機酸或無機酸。 甲 1241296 第三步係具有化學式(n )之α,沒-未飽和酸衍生 物及具有化學式(VI)之亞胺之縮合,其中1至2當 里之具有化學式(Π )之α,/3 -未飽和酸衍生物係於驗 (〇·1至2當量)及聚合物抑制劑(〇 〇〇5至〇·2當量) 存在下’於回流溫度(〜1 5〇)之有機溶劑中,與 1當量之具有化學式(V!)之亞胺反應。, NH HN—NΛ and n = \ (VI) R8 Figure 4 垸 αΠΙΆ represents nitrile with one to ten carbon atoms, methylbenzyl, -methylbenzyl, ~ substituted base,> ethyl gluten can be used as cereal Qiyanyuan, Dichloromethane, P, from: ―gas ethane or such as: methanol, ethanol, propanol or: the catalyst may not be added '' or the catalyst may be organic such as: U ϊ lithic acid, sulfuric acid or hydrochloric acid Acid or inorganic acid. A1241296 The third step is the condensation of α, n-unsaturated acid derivative with chemical formula (n) and imine with chemical formula (VI), among which 1 to 2 miles is α, / 3 with chemical formula (Π) -Unsaturated acid derivatives are present in the organic solvent at the reflux temperature (~ 150) in the presence of the test (0.1 to 2 equivalents) and the polymer inhibitor (0.05 to 0.2 equivalents), React with 1 equivalent of imine of formula (V!).
ΗΗ
RR
RsRs
Solvent N polymer inhibitor J| baseSolvent N polymer inhibitor J | base
圖5 圖5係顯不具有化學式(jj )之^,点-未飽和酸衍生物 及具有化學式(VI)之亞胺之縮合流程,其中Ri、R2、 R3及R8與前述定義相同,且Rs代表鹵素原子或 OR9,其中R9代表具有一至六個碳原子之烷基自由 基;且R6代表具有一至六個碳原子之烷基自由基;溶 =可為乙腈、曱苯、二曱苯、氯苯、三氯曱烷、二氣 t烷或1,2-二氣乙烷;前述鹼可為碳酸金屬鹽或碳酸 虱金屬鹽,其中前述金屬可為鋰、鈉、鉀、铷、鉋、 鈹、鎂、鈣、勰或鋇等;前述聚合物抑制劑可使用氫 醒或單甲基乙醚氫醌。 最後一步係製備具有化學式(z )之三唑嘧啶衍 生物,其中具有化學式(观)之亞胺係於酸(〇· 1至 10當量)、水及溶劑存在下,於室溫至回流溫度中水 1241296 解。Figure 5 Figure 5 shows the condensation process of ^, dot-unsaturated acid derivative without chemical formula (jj) and imine with chemical formula (VI), where Ri, R2, R3, and R8 are the same as defined above, and Rs Represents a halogen atom or OR9, where R9 represents an alkyl radical having one to six carbon atoms; and R6 represents an alkyl radical having one to six carbon atoms; solvent = can be acetonitrile, toluene, dibenzobenzene, chlorine Benzene, trichloromethane, dioxane, or 1,2-dioxane; the aforementioned base may be a metal carbonate or a metal carbonate, wherein the aforementioned metal may be lithium, sodium, potassium, thallium, planer, beryllium , Magnesium, calcium, rubidium, or barium; etc .; the aforementioned polymer inhibitors can be hydrogen awakening or monomethyl ether hydroquinone. The last step is to prepare a triazolopyrimidine derivative having the chemical formula (z), wherein the imine having the chemical formula (view) is in the presence of an acid (0.1 to 10 equivalents), water and a solvent at room temperature to reflux temperature. Water 1241296 solution.
(VIII) (I) 圖6(VIII) (I) Figure 6
圖6係顯示製備具有化學式(I )之三唾η密唆衍生物 之流程’其中Rl、R2、R3及Rs與前述定義相同;前 述酸可為如:鹽酸、硫酸、乙酸或草酸等之無機酸咬 有機酸;前述溶劑可使用水、曱醇、乙醇、乙精、甲 笨、二曱笨、氯苯、三氯甲烷、二氯甲烷或1,2_二氯 下列之實施例係進一步描述本發明,但不限制本 發明之範圍。 【實施方式】FIG. 6 shows a process for preparing a sialene derivative with the chemical formula (I), wherein R1, R2, R3, and Rs are the same as the foregoing definitions; the foregoing acids may be inorganic acids such as hydrochloric acid, sulfuric acid, acetic acid, or oxalic acid, etc. Acid bites organic acids; the aforementioned solvents can be water, methanol, ethanol, ethyl acetate, methylbenzyl, dibenzyl, chlorobenzene, chloroform, dichloromethane, or 1,2-dichloro. The following examples are further described. The invention does not limit the scope of the invention. [Embodiment]
實施例1 N5-丙基_1H-[1,2,4]三唑-3,5-二胺之製備Example 1 Preparation of N5-propyl_1H- [1,2,4] triazole-3,5-diamine
於一 1〇升,配備有回流濃縮器、溫度計、注入漏 斗及機械攪拌器之四頸燒瓶中,將12〇〇 g( 813 m〇le ) 之一*曱基乱基一硫基亞胺基♦酸S旨溶解於6 Kg之異丙 醇中。於2小時内室溫下滴入538 8.94 mole)之正 10 1241296 丙胺’再攪拌反應混合物20分鐘後,升高溫度至回流 溫度並奴慢加入丨224 g( 2〇·8 mole)之聯胺(85% ), 接著回流2〜3小時。接著於減壓下蒸餾出80%異丙 醇,並冷卻殘餘物至5〜1(rc。過濾及乾燥後,獲得白 色固體之N5-丙基-1H_[1,2,4]三唑-3,5-二胺。產量為 1075 g( AI 98% ,理論值 92% )。熔點為 148〜149°C。 ^ 實施例2 Ν'亞苄基-N5-丙基_1H_[1,2,4]三唑_3,5_二胺之 製備In a 10 liter four-necked flask equipped with a reflux concentrator, a thermometer, an injection funnel, and a mechanical stirrer, one of 12,000 g (813 mole) of a sulfanyl-thioimino group ♦ Acid S is intended to be dissolved in 6 Kg of isopropanol. 538 8.94 mole) of n- 10 1241296 propylamine was added dropwise at room temperature over 2 hours. After stirring the reaction mixture for another 20 minutes, the temperature was raised to reflux temperature and 224 g (20.8 mole) of hydrazine was added slowly. (85%), followed by reflux for 2 to 3 hours. Then, 80% isopropanol was distilled off under reduced pressure, and the residue was cooled to 5 to 1 (rc. After filtration and drying, N5-propyl-1H_ [1,2,4] triazole-3 was obtained as a white solid. , 5-diamine. Yield is 1075 g (AI 98%, theoretical value 92%). Melting point is 148 ~ 149 ° C. ^ Example 2 N'benzylidene-N5-propyl_1H_ [1,2, 4] Preparation of triazole_3,5_diamine
HN-N 八。h 方法1 於配備有回流濃縮器、溫度計及機械攪拌器之5 升燒瓶中裝入 251.8 g( 1·75 mole )之 N5_ 丙基 2 41 三唑 _3,5_ 二胺、1.24 升之甲醇及 1948g (1 84m〇’1〇 之苯甲醛,接著加熱回流6〜10小時。以Lc確定反應 結束後(N5-丙基_1Η_Π,2,4]三唑_3,5_二胺之峰區小^ 1% ),2/3體積之溶劑於減壓下由混合物中蒸餾出。、 將殘餘物冷卻至室溫,則沈澱出黃色固體 基-n、丙基-m-n,2,4]三唾_3,5_二胺。利用過據來= 集沈澱物,乾燥後獲得所希望之產物381〜389 98% ,理論值93〜95% ) 。 g純度 當甲醇以乙醇、甲苯或乙腈取代時,亦可得到相 11 I241296 =之結果。當5·2 g ( 0.087 m〇le)之乙酸使用於這些 情況下或/且於共沸狀態下移除水’反應時間可縮^ 至1〜4小時,且產量及純度無明顯改變。 方法2 於配備有回流濃縮、溫度計及機械授拌器之5 升燒瓶中裝入 251.8 g( 1.75 mole)之 N5-丙基 _1H_[1,2 4] 三唑-3,5-二胺、1·75 升之甲苯、203.4 g ( 1.92 m〇i’〇 之苯曱搭及5.2 g ( 0.087 mole)之乙酸,接著加熱回 流1〜3小時。反應中,形成之水為副產物,且於共沸鲁 狀態下移除。以LC確定反應結束後(N5-丙基 _111-[1,2,4]二0坐-3,5-^一胺之峰區小於1% ),冷卻混合 物並得到原始之N3·亞苄基-N5·丙基-1H-[1,2,4]三峻 3,5 -二胺之懸浮液’其不經純化而用於下一階段。 實施例3 2-(亞节基-胺基)-6 -曱基_4_丙基_4H-[1,2,4]三0坐5-a] 嘧啶-5-酮之製備HN-N VIII. h Method 1 In a 5 liter flask equipped with a reflux concentrator, thermometer and mechanical stirrer, 251.8 g (1.75 mole) of N5_propyl 2 41 triazole_3,5_ diamine, 1.24 liters of methanol and 1948 g (1 84 m〇'10 of benzaldehyde, followed by heating to reflux for 6 to 10 hours. After the completion of the reaction was determined by Lc (N5-propyl_1Η_Π, 2, 4,] triazole_3,5_diamine peak region ^ 1%), 2/3 volume of solvent was distilled off from the mixture under reduced pressure., The residue was cooled to room temperature, and a yellow solid-n, propyl-mn, 2, 4] was precipitated. Sial_3,5_diamine. Use the data to collect the precipitate, and obtain the desired product 381 ~ 389 98% after drying, theoretical value 93 ~ 95%). g purity When methanol is replaced by ethanol, toluene or acetonitrile, the result of phase 11 I241296 = can also be obtained. When 5.2 g (0.087 mole) of acetic acid is used in these cases or / and the water is removed in an azeotropic state, the reaction time can be reduced to 1 to 4 hours, and the yield and purity are not significantly changed. Method 2 A 5 liter flask equipped with reflux concentration, thermometer and mechanical stirrer was charged with 251.8 g (1.75 mole) of N5-propyl_1H_ [1,2,4] triazole-3,5-diamine, 1.75 liters of toluene, 203.4 g (1.92 m mi′〇 of benzene, and 5.2 g (0.087 mole) of acetic acid, followed by heating under reflux for 1 to 3 hours. In the reaction, the formed water is a by-product, and Removed under azeotropic state. After the reaction was confirmed by LC (N5-propyl_111- [1,2,4] dioxo-3,5- ^ monoamine peak area is less than 1%), the mixture was cooled. And the original N3 · benzylidene-N5 · propyl-1H- [1,2,4] sanjun 3,5-diamine suspension was obtained, which was used in the next stage without purification. Example 3 Preparation of 2- (benzylidene-amino) -6-fluorenyl_4_propyl_4H- [1,2,4] trio-5-a] pyrimidin-5-one
方法1 於配備有回流濃縮器、溫度計及機械授拌器之5 升燒瓶中裝入401.03 g ( 1.75 mole)之N3-亞亨基_nl 丙基-111-[1,2,4]三唑-3,5-二胺、253 §(1.83111〇16)之 碳酸鉀、250 g ( 1.92 mole)之甲基2-曱氧基曱基 12 1241296 广、Ug( 0.009 mole)之對甲氧酚及175〇如 乙t :著加熱回流24〜28小時。於減壓下蒸館出. 乙月士加入…U2-二氣乙燒萃取混合物。將 產物一4tf從萃取物中移除,乾燥後獲得所希望之 產物406〜432 g (理論值之77〜82% )。 、田以甲笨取代乙腈時亦得到相似之結果。 方法2 之甲:T ^1.83 m〇10 之碳酸鉀、250 g( U2 mole) 土 -甲氧基_甲基丙烯酸酯及1.1 g ( 〇 009鲁 N3_亞¥盆甲5乳酚加入貫施例2 (方法2 )中製備出之 土 N _丙基_1]^[1,2,4]三唑_3,5_二胺之懸浮 ί丨^ 2〜2〇小時後,將混合物冷卻至室溫,並加 甲基-4-丙以過濾收集固體之2_(亞苄基-胺基)_6_ 、、看舲八λ、土々^^1,2,4]三哇以^^嘴咬^一酮’並將過 =Ρ二兩層’其中有機層可以再利用於實施例2。 禾經純化之馬“ -4Η-[1,2 41」、^ (亞¥基_胺基卜&甲基冰丙基 ’ j~%Ll,5_a]嘧啶_5_酮係用於下一階段。 2_ A 實施例4 胺基-6-甲基_4_丙基-4h-[i,2,4]三唑[l,5-a]嘧 啶-5-酮之製備Method 1 A 5-liter flask equipped with a reflux concentrator, a thermometer, and a mechanical stirrer was charged with 401.03 g (1.75 mole) of N3-hytenyl_nl propyl-111- [1,2,4] triazole -3,5-diamine, 253 § (1.83111〇16) potassium carbonate, 250 g (1.92 mole) of methyl 2-ethoxyfluorenyl 12 1241296, Ug (0.009 mole) of p-methoxyphenol and 175. Such as B t: heating and refluxing for 24 to 28 hours. Evaporate under reduced pressure. Add Eyers to ... Product 4tf was removed from the extract and dried to obtain the desired product 406-432 g (77-82% of theory). A similar result was obtained when Tian replaced acetonitrile with methylbenzyl. Method 2: T ^ 1.83 m〇10 potassium carbonate, 250 g (U2 mole) of earth-methoxy-methacrylate and 1.1 g (〇009 鲁 N3_ 亚 ¥ penjia 5 lactol added to the application The soil N_propyl_1] ^ [1,2,4] triazole_3,5_diamine suspended in Example 2 (Method 2) was prepared. After 2 ~ 20 hours, the mixture was cooled. To room temperature, and add methyl-4-propane to collect 2_ (benzylidene-amino) -6_ of the solid by filtration, look at 舲 λ, soil ^^ 1,2,4] The organic layer can be reused in Example 2. The purified horse "-4Η- [1,224", & Methyl benzyl'j ~% Ll, 5_a] pyrimidin_5_one is used in the next stage. 2_ A Example 4 Amine-6-methyl_4_propyl-4h- [i, Preparation of 2,4] triazole [l, 5-a] pyrimidin-5-one
N H2N_ 、N^V" 將 17 5 0 1 之2Ν鹽酸(3.5mole)加入實施例3 13 1241296 (方法2)中製備出之原始2_ (亞苄基_胺基)_6_甲基 丙基4^1[1,2,4]二唾[1,5_3]。密12定-5-酮。加熱混合物 至^〜70 C 30分鐘,並於減壓下,於共沸狀態下移除 水。解,,甲醛。完全移除苯甲醛後,冷卻混合物並以 45%氫氧化鈉水溶液將pH值調至7〜8。 之懸浮液,並乾燥後獲得淡黃色固體之2_胺基_6_曱于^ 丙基 _4H_[1,2,4]二唾[i,5_a]嘧咬-5_ 酮(純度 98 '。產量為264〜275 g (由實施例2得之理論值之 73〜76% )。 當 醇時,N H2N_, N ^ V " Add 17 5 0 1 2N hydrochloric acid (3.5mole) to the original 2_ (benzylidene_amino) _6_methylpropyl 4 prepared in Example 3 13 1241296 (Method 2) ^ 1 [1,2,4] two saliva [1,5_3]. Sediment 12-5-one. The mixture was heated to ^ ~ 70 C for 30 minutes, and water was removed under reduced pressure in an azeotropic state. Solution, formaldehyde. After the benzaldehyde was completely removed, the mixture was cooled and the pH was adjusted to 7-8 with a 45% aqueous sodium hydroxide solution. The suspension was dried and dried to obtain 2-amino-6-hydroxypropyl-4-H- [1,2,4] bisial [i, 5_a] pyrimid-5_one (purity 98 ') as a pale yellow solid. The yield was 264 to 275 g (73 to 76% of the theoretical value obtained from Example 2). When alcohol,
以1500 ml之曱醇作為溶劑且於室溫下水解曱 亦可得到相似之結果。Similar results were obtained using 1500 ml of methanol as the solvent and hydrolyzing the europium at room temperature.
1414
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW91108486A TWI241296B (en) | 2002-04-24 | 2002-04-24 | Process for preparing triazolopyrimidine derivatives |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW91108486A TWI241296B (en) | 2002-04-24 | 2002-04-24 | Process for preparing triazolopyrimidine derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
TWI241296B true TWI241296B (en) | 2005-10-11 |
Family
ID=37013919
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW91108486A TWI241296B (en) | 2002-04-24 | 2002-04-24 | Process for preparing triazolopyrimidine derivatives |
Country Status (1)
Country | Link |
---|---|
TW (1) | TWI241296B (en) |
-
2002
- 2002-04-24 TW TW91108486A patent/TWI241296B/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI250155B (en) | Preparation of oxazolidinones | |
JP3803292B2 (en) | Method for producing thiazolidine | |
US7799930B2 (en) | 1-alkyl-3-aminoindazoles | |
KR20090098325A (en) | Process for preparing racemic or optically pure (s)-oxiracetam | |
US11390633B2 (en) | Methods of preparing cytotoxic benzodiazepine derivatives | |
US12054489B2 (en) | Substituted amidrazones as intermediates in the process for preparing soluble guanylate cyclase stimulators | |
JPH0641095A (en) | Antidepressant 3-halophenylpiperazinyl-propyl derivative of substituted triazolone and triazoledione | |
US20110207965A1 (en) | Process for preparing cinacalcet | |
US20160108053A1 (en) | Processes for making ponatinib and intermediates thereof | |
JP2010510253A (en) | Novel process for the preparation of 4,4 '-(1-methyl-1,2-ethanediyl) -bis- (2,6-piperazinedione) | |
TWI241296B (en) | Process for preparing triazolopyrimidine derivatives | |
JP2003500479A (en) | Catechol hydrazone derivative, production method and pharmaceutical composition containing the same | |
JP5551673B2 (en) | Low VOC polyamine | |
JP6368043B2 (en) | Method for producing tricyclic lactam compound | |
JPH09507837A (en) | Method for producing polyaza macrocycle | |
TWI361807B (en) | Process for preparing substituted 4-alkoxycarbonyl-3-aminothiophenes | |
US20070106083A1 (en) | Process for preparing 4-aminotetrahydropyran compound and an acid salt thereof, synthetic intermediate thereof and process for preparing the same | |
JP2004503543A (en) | Method for producing 1,2,4-triazolin-5-one derivative | |
WO2007023822A1 (en) | Method for producing 1-substituted-5-acylimidazole compound | |
US7951952B2 (en) | Method for preparing N-aminopiperidine and its salts | |
DK171451B1 (en) | Alkyl [1 - [(2-phenoxyethyl) amine] propylidene] hydrazinecarboxylate acid addition salts and process for their preparation | |
TW577877B (en) | Improved methods of preparing 4-cyano-4-(substituted indazole)cyclohexane-carboxylic acids useful as PDE4 inhibitors | |
US11066354B2 (en) | Process for mono N-alkylation of aminophenol | |
JP2006505584A (en) | Method for producing pyrazole compound | |
JP4305747B2 (en) | 2-Phenyl-4- (dichlorophenyl) imidazole compound |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK4A | Expiration of patent term of an invention patent |